Sara Zarnegar-Lumley

8PUBLICATIONS
43CO-AUTHORS
Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsImmunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid Leukemia.

Lauren M Harmon, Zachary S Hattig, Yizhou Peter Huang

|Nov 30, 2023
Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.

Erica Brivio, Edoardo Pennesi, Marieke E Willemse

|Jul 12, 2023
Children's Oncology Group's 2023 blueprint for research: Young investigators.

Adam J Esbenshade, Lisa S Kahalley, Birte Wistinghausen

|Jun 02, 2023
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.

Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing

|Jun 06, 2022
Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies.

Sara Zarnegar-Lumley, Kenneth J Caldwell, Jeffrey E Rubnitz

Pageof 2